Seaport Therapeutics raised $100 million in an oversubscribed Series A led by ARCH Venture Partners, Sofinnova Investments and Third Rock Ventures to support the development of a novel clinical-stage pipeline of neuropsychiatric medicines.
Amount Raised
$100 Million
Round Type
Series A
BostonBiotechnologyTherapeuticsPharmaceuticalBiopharmaInvestors
Description
Seaport Therapeutics, the latest Founded Entity by PureTech, has successfully raised $100 million in an oversubscribed Series A financing. The funding will be used to support the development of a novel clinical-stage pipeline of neuropsychiatric medicines.
Quick answer
Seaport Therapeutics raised $100 Million in a Series A round, dated April 9, 2024. Investors: Third Rock Ventures, Sofinnova Investments and ARCH Venture Partners. Seaport Therapeutics is based in Boston, Massachusetts, United States.
- How much did Seaport Therapeutics raise?
- Seaport Therapeutics raised $100 Million in a Series A round on April 9, 2024.
- Who invested in Seaport Therapeutics?
- Third Rock Ventures, Sofinnova Investments and ARCH Venture Partners are named as investors in this round.
- What does Seaport Therapeutics do?
- Seaport Therapeutics is a clinical-stage biopharmaceutical company advancing the development of novel neuropsychiatric medicines in areas of high unmet patient needs.
- Where is Seaport Therapeutics based and how big is it?
- Seaport Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Seaport Therapeutics?
- Fundz holds 1 contact at Seaport Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Seaport Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- MyMD Pharmaceuticals raised $7M (Post-IPO Equity) on May 21, 2024.
- MyMD Pharmaceuticals raised $27M on May 20, 2024.
- MyMD Pharmaceuticals raised $15M on May 20, 2024.
- Ajax Therapeutics, Inc. raised $95M (Series C) on May 13, 2024.
- Bio Green Med Solution, Inc. raised $8M on May 2, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
Who to call at Seaport Therapeutics, and when
A new round usually means Seaport Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Seaport Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Seaport Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Seaport Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Seaport Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansSeaport Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.